The biotech industry displayed remarkable resilience in 2024, with top-performing stocks being led by companies like Bright Minds Biosciences, Monopar Therapeutics, and Summit Therapeutics. The key drivers for strong stock performance last year were regulatory approval, medical breakthroughs, and successful clinical trials progress. Notable emerging trends in 2024 included therapies inspired by psychedelics, radiopharmaceuticals, advancements in gene-related therapies, and the rise of bispecific antibodies in the field of cancer treatment.
Akamai warns of active attacks from new Mirai variant
Online backbone provider, Akamai, has sounded an alert regarding a new botnet (Aquabotv3) based on the malware, Mirai. Discovered by Akamai researchers Larry Cashdollar and
